Gene · 965
Papers4,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 4,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A one-way street recognition approach to mediate allogeneic immune cell therapies. | Cell Stem Cell | 2024 | 39241752 | PubTator, text mining | PubMed |
| CD58 defines regulatory macrophages within the tumor microenvironment. | Commun Biol | 2024 | 39164573 | PubTator, text mining | PubMed |
| The Immunological Profile of Adipose Mesenchymal Stromal/Stem Cells after Cell Expansion and Inflammatory Priming. | Biomolecules | 2024 | 39062566 | PubTator, text mining | PubMed |
| Plasma circulating tumour DNA is a better source for diagnosis and mutational analysis of IVLBCL than tissue DNA. | J Cell Mol Med | 2024 | 39054569 | PubTator, text mining | PubMed |
| Modified Sanliangsan Improved Sjogren's Syndrome Complicated with Interstitial Lung Disease by Suppressing Serum MUC1 Levels. | ACS Omega | 2024 | 39035955 | PubTator, text mining | PubMed |
| Genetic ablation of adhesion ligands mitigates rejection of allogeneic cellular immunotherapies. | Cell Stem Cell | 2024 | 38981470 | PubTator, text mining | PubMed |
| IL-10 indirectly modulates functional activity of CD4+CD28null T-lymphocytes through LFA-3 and HLA class II inhibition. | Immunology | 2024 | 38922883 | PubTator, text mining | PubMed |
| Characterization of Immune Infiltrate Along the Leading Edge of Differentiated Thyroid Cancer. | Thyroid | 2024 | 38916182 | PubTator, text mining | PubMed |
| Human dendritic cell interactions with the zoonotic parasite Cryptosporidium parvum result in activation and maturation. | Front Immunol | 2024 | 38799470 | PubTator, text mining | PubMed |
| The Evolving Landscape of Flowcytometric Minimal Residual Disease Monitoring in B-Cell Precursor Acute Lymphoblastic Leukemia. | Int J Mol Sci | 2024 | 38732101 | PubTator, text mining | PubMed |
| Clinical significance of immune-related antigen CD58 in gliomas and analysis of its potential core related gene clusters. | Heliyon | 2024 | 38699747 | PubTator, text mining | PubMed |
| Comprehensive Genetic Profiling Reveals Frequent Alterations of Driver Genes on the X Chromosome in Extranodal NK/T-cell Lymphoma. | Cancer Res | 2024 | 38657099 | PubTator, text mining | PubMed |
| CD58 Alterations Govern Antitumor Immune Responses by Inducing PDL1 and IDO in Diffuse Large B-Cell Lymphoma. | Cancer Res | 2024 | 38635903 | PubTator, text mining | PubMed |
| Functional genomics identifies N-acetyllactosamine extension of complex N-glycans as a mechanism to evade lysis by natural killer cells. | Cell Rep | 2024 | 38619967 | PubTator, text mining | PubMed |
| Biomarker discovery with quantum neural networks: a case-study in CTLA4-activation pathways. | BMC Bioinformatics | 2024 | 38609844 | PubTator, text mining | PubMed |
| HSPA4 upregulation induces immune evasion via ALKBH5/CD58 axis in gastric cancer. | J Exp Clin Cancer Res | 2024 | 38589927 | PubTator, text mining | PubMed |
| Deletion of the TMEM30A gene enables leukemic cell evasion of NK cell cytotoxicity. | Proc Natl Acad Sci U S A | 2024 | 38557174 | PubTator, text mining | PubMed |
| Meta-analysis of the Selected Genetic Variants in Immune-Related Genes and Multiple Sclerosis Risk. | Mol Neurobiol | 2024 | 38478144 | PubTator, text mining | PubMed |
| Germline variants of DNA repair and immune genes in lymphoma from lymphoma-cancer families. | Int J Cancer | 2024 | 38446987 | PubTator, text mining | PubMed |
| The influence of cytotoxic drugs on the immunophenotype of blast cells in paediatric B precursor acute lymphoblastic leukaemia. | Radiol Oncol | 2024 | 38378030 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/965/papers?page=6